vs
Side-by-side financial comparison of Ambow Education Holding Ltd. (AMBO) and Opus Genetics, Inc. (IRD). Click either name above to swap in a different company.
Opus Genetics, Inc. is the larger business by last-quarter revenue ($3.9M vs $2.8M, roughly 1.4× Ambow Education Holding Ltd.). On growth, Ambow Education Holding Ltd. posted the faster year-over-year revenue change (15.3% vs -10.2%).
Ambow Education Holding Ltd. is a China-focused education service provider that offers personalized learning solutions, professional career training programs, and K-12 after-school tutoring services. It partners with educational institutions and enterprises to deliver technology-integrated learning resources for learners of all age groups across mainland China.
Opus Genetics, Inc. is a clinical-stage biotechnology company specializing in the development of targeted gene therapies for inherited retinal diseases. It focuses on addressing unmet medical needs for patients living with rare, vision-threatening ocular conditions, with operations centered on advancing accessible therapeutic candidates for global rare disease patient populations.
AMBO vs IRD — Head-to-Head
Income Statement — Q2 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $2.8M | $3.9M |
| Net Profit | $1.8M | — |
| Gross Margin | 53.3% | — |
| Operating Margin | 11.9% | — |
| Net Margin | 64.2% | — |
| Revenue YoY | 15.3% | -10.2% |
| Net Profit YoY | 1343.1% | 53.0% |
| EPS (diluted) | $0.03 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $3.9M | ||
| Q3 25 | — | $3.1M | ||
| Q2 25 | $2.8M | $2.9M | ||
| Q1 25 | — | $4.4M | ||
| Q4 24 | — | $4.3M | ||
| Q3 24 | — | $3.9M | ||
| Q2 24 | $2.4M | $1.1M | ||
| Q1 24 | — | $1.7M |
| Q4 25 | — | — | ||
| Q3 25 | — | $-17.5M | ||
| Q2 25 | $1.8M | $-7.4M | ||
| Q1 25 | — | $-8.2M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $-7.5M | ||
| Q2 24 | $123.0K | $-7.8M | ||
| Q1 24 | — | $-7.1M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 53.3% | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 55.6% | — | ||
| Q1 24 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | — | -269.9% | ||
| Q2 25 | 11.9% | -309.0% | ||
| Q1 25 | — | -227.2% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | -207.1% | ||
| Q2 24 | 2.7% | -748.9% | ||
| Q1 24 | — | -450.5% |
| Q4 25 | — | — | ||
| Q3 25 | — | -566.9% | ||
| Q2 25 | 64.2% | -257.5% | ||
| Q1 25 | — | -187.5% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | -194.6% | ||
| Q2 24 | 5.1% | -698.3% | ||
| Q1 24 | — | -415.3% |
| Q4 25 | — | — | ||
| Q3 25 | — | $-0.25 | ||
| Q2 25 | $0.03 | $-0.12 | ||
| Q1 25 | — | $-0.24 | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $-0.29 | ||
| Q2 24 | $0.00 | $-0.30 | ||
| Q1 24 | — | $-0.29 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $4.1M | $45.1M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $8.6M | $15.3M |
| Total Assets | $23.2M | $50.2M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $45.1M | ||
| Q3 25 | — | $30.8M | ||
| Q2 25 | $4.1M | $32.4M | ||
| Q1 25 | — | $41.8M | ||
| Q4 24 | — | $30.3M | ||
| Q3 24 | — | $36.6M | ||
| Q2 24 | $1.6M | $41.4M | ||
| Q1 24 | — | $47.2M |
| Q4 25 | — | $15.3M | ||
| Q3 25 | — | $6.0M | ||
| Q2 25 | $8.6M | $17.5M | ||
| Q1 25 | — | $5.1M | ||
| Q4 24 | — | $6.7M | ||
| Q3 24 | — | $34.3M | ||
| Q2 24 | $6.6M | $40.6M | ||
| Q1 24 | — | $46.1M |
| Q4 25 | — | $50.2M | ||
| Q3 25 | — | $36.1M | ||
| Q2 25 | $23.2M | $38.7M | ||
| Q1 25 | — | $48.2M | ||
| Q4 24 | — | $36.9M | ||
| Q3 24 | — | $40.4M | ||
| Q2 24 | $17.6M | $44.8M | ||
| Q1 24 | — | $51.8M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $-35.3M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $-35.3M | ||
| Q3 25 | — | $-6.2M | ||
| Q2 25 | — | $-10.3M | ||
| Q1 25 | — | $-9.0M | ||
| Q4 24 | — | $-25.6M | ||
| Q3 24 | — | $-5.1M | ||
| Q2 24 | — | $-7.3M | ||
| Q1 24 | — | $-5.7M |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
